Skip to main content
. Author manuscript; available in PMC: 2016 Jul 12.
Published in final edited form as: Curr Opin Mol Ther. 2004 Dec;6(6):657–665.
Developer Country Status Indication Date Reference
PharmaMar SA France Phase II Psoriasis 28-OCT-04 567635
PharmaMar SA Spain Phase II Liver tumor 29-MAY-03 491229
PharmaMar SA Spain Phase II Psoriasis 28-OCT-04 567635
PharmaMar SA Western Europe Phase II Melanoma 19-JUL-04 549751
PharmaMar SA Western Europe Phase II Non-small-cell lung cancer 19-JUL-04 549751
PharmaMar SA Netherlands Phase I Prostate tumor 01-FEB-01 402916
PharmaMar SA Spain Phase I Carcinoma 04-JAN-01 394993
PharmaMar SA Spain Phase I Colon tumor 04-JAN-01 394993
PharmaMar SA Spain Phase I Prostate tumor 04-JAN-01 394993
PharmaMar SA Spain Phase I Solid tumor 04-JAN-01 394993
PharmaMar SA Spain Discovery Breast tumor 26-MAR-01 402916
PharmaMar SA Spain Discovery Ovary tumor 26-MAR-01 402916